Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Asharq Al-Awsat
Asharq Al-Awsat
World
Asharq Al-Awsat

UAE Approves Sinopharm’s Protein-based Vaccine

Test tubes are seen in front of a displayed Sinopharm logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration

The United Arab Emirates has approved emergency use of Sinopharm's protein-based COVID-19 vaccine and it will be available to the public as a booster dose starting January 2022, the health ministry said.

The vaccine will be produced and distributed by a joint venture between the UAE's Group 42 and China National Biotec Group (CNBG), a unit of China National Pharmaceutical Group (Sinopharm), the ministry said in a statement on state media on Monday, Reuters reported.

The approval came following a UAE-based study that included individuals who were previously vaccinated with two doses of Sinopharm CNBG's inactivated vaccine, the ministry added.

The UAE on Monday reported 1,732 new coronavirus cases and one death. Authorities said around 91% of the population of some 10 million had been fully vaccinated.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.